Introduction
============

Cervical cancer is one of the most common cancers of the female reproductive system. The number of women with newly diagnosed cervical cancer increases and the percentage of women with cervical cancer in all gynaecological cancers also increases annually in China[@B1]. Radical hysterectomy with pelvic lymphadenectomy is the standard surgical treatment for patients with stage IA2-IB1 cervical cancer. But the wide excision of parametrial tissues (≥3cm) increases the complications during and after the operation, especially the complications of the urinary system, which severely affect the life quality and the following adjuvant therapy[@B2], even in robotic sugeries[@B3]. Can we decrease the complication by appropriately narrowing the scope of operation in selected patients without affecting the outcomes? How can we choose the proper patients? Therefore, we performed this retrospective analysis and try to answer these questions.

Materials and methods
=====================

Data on this retrospective study was collected from The Hospital of Obstetrics & Gynaecology, Shanghai Medical College, Fudan University, Shanghai, China from Jan 2008 to Dec 2011, with the approval of Ethics Committee of hospital. This hospital serves a diverse urban and rural population with over 1.3 million outpatients and 40,000 inpatients annually, and is a largest specialised referral obstetrics & gynaecology teaching hospital located in Shanghai which is the largest city in China with 20 million populations.

The pathological and clinical data of patients with stage IA2-IB1 cervical cancer who received radical hysterectomy with pelvic lymphadenectomy in this OB/GYN Hospital were collected and analyzed. All those patients received either chemotherapy or radiotherapy before the operations were excluded. This retrospective study was exempt from IRB approval because we only reviewed the clinical histories without revolving any information about patients\' private.

Immunohistochemical examinations of D2-40 and CD31 were described as negative, positive and strong positive. Strong positive of D2-40 and CD31 meant D2-40 and CD31 positive and also with tumor thrombus.

Those patients with diameter of tumor ≤2cm, depth of cervical myometrial invasion\<1/2 and without lymph vascular involvement formed the low-risk group, and the others formed the high-risk group. Both groups were further divided into two groups according to the resection width of parametrial tissues. Those patients with the resection width of parametrial tissues of both sides ≥3cm formed group A, and those with the resection width of parametrial tissues of at least one side \<3cm formed group B.

Statistical analysis
--------------------

The single factor analysis of the pathological and clinical data of patients was made with χ^2^ test. The relationship of the resection width of parametrial tissues and the patients\' outcomes was analyzed with χ^2^ test and log-rank. P-values \<0.05 were considered statistically significant.

Results
=======

There were 880 cases of stage IA2-IB1 cervical cancer received radical hysterectomy with pelvic lymphadenectomy in this hospital from Jan 2008 to Dec 2011. The whole picture of these patients was showed as Table [1](#T1){ref-type="table"}. The average age was 45.7±8.7. Among 513 patients with well following-up, there were 31 cases (6.0%) recurred and 26 cases (5.1%) died of cervical cancer during the follow-up period (from 2 months to 66 months, averaged 39 months).

The single factor analysis showed that the diameter of tumor was separately related to the depth of cervical myometrial invasion (P=0.000), the diameter of tumor and the depth of cervical myometrial invasion were both related to lymph vascular involvement (P=0.000), the diameter of tumor, the depth of cervical myometrial invasion and lymph vascular involvement were all related to parametrial metastases (P=0.000), shown as Table [2](#T2){ref-type="table"}.

Immunohistochemical examinations of D2-40 were applied to 606 cases and examinations of CD31 were applied to 563 cases. CD31 strong positive (P=0.002) and D2-40 strong positive (P=0.016) were also the high-risk factors of parametrial metastases (shown as Table [2](#T2){ref-type="table"}).

The χ^2^test showed that parametrial metastases were related to the recurrence (P=0.030) and the death (P=0.019) of cervical cancer, but the immunohistochemical indexes were not related to the recurrence or the death of cervical cancer (P\>0.05), shown as Table [3](#T3){ref-type="table"}.

The parametrial metastases rate and transfer rate of high-risk group were 4.1% and 9.5%, while those of low-risk group were 0% and 1.4%, shown as Figure [1](#F1){ref-type="fig"}. The difference of progression free survival (PFS, P=0.006) and overall survival (OS, P=0.004)) of low-risk and high-risk groups was statistically significant. The resection width of parametrial tissues (varied mostly due to tumor size, performance of different surgeons and the objective conditions of patients) had no statistically significant effect on the recurrence (P=1.000) and the death (P=1.000) of low-risk patients, shown as Table [4](#T4){ref-type="table"}. The resection width of parametrial tissues also had no statistically significant effect on the recurrence (P=0.082) and the death (P=0.147) of high-risk patients, shown as Table [4](#T4){ref-type="table"}. The resection width of parametrial tissues also had no statistically significant effect on the PFS (P=0.610) and OS (P=0.608) of low-risk patients, shown as Figure [2](#F2){ref-type="fig"}.

Discussion
==========

According to the guideline of NCCN 2014, the standard surgical treatment for patients with stage IA2-IB1 cervical cancer is radical hysterectomy with pelvic lymphadenectomy, which demands wide excision of parametrial tissues (cardinal ligament 3-4cm, uterosacral ligament≥3cm and all vaginal connective tissues). The wide excision of parametrial tissues may block pelvic nerves which locate in cardinal ligament and uterosacral ligament, and increase the complications during and after the operation, especially the complications of the urinary system, which may severely affect the life quality and the following adjuvant therapy [@B2],[@B3]. Studies of large samples have shown that the parametrial metastases rate of stage 1B1 cervical cancer is about 5.4-10% [@B4]-[@B5]. The parametrial metastases rate of those patients with the diameter of tumor ≤2cm, the depth of cervical myometrial invasion\<10 mm and without lymph vascular involvement is about 0-1.1% [@B4]-[@B6], which suggest that these factors can be considered as low-risk factors. On the other hand, there was a report of 37 patients with stage 1A2-1B1 cervical cancer showing that the parametrial metastases rate was 33% for all patients and 4.5% for those with the diameter of tumor ≤2cm and without lymph vascular involvement[@B7], but this result should be doubted because of the limited cases and the miss of considering the depth of cervical myometrial invasion.

In our study, 880 patients with stage IA2-IB1 cervical cancer were analyzed and the total parametrial metastases rate was 2.4%. The single factor analysis showed that the diameter of tumor \>2cm, the depth of cervical myometrial invasion ≥1/2 and lymph vascular involvement were all independent high-risk factors of parametrial metastases. There were no parametrial metastases in cases with the diameter of tumor ≤2cm, the depth of cervical myometrial invasion\<1/2 and without lymph vascular involvement at the same time, which suggested that over resection of parametrial tissues was not wise for these low-risk patients. Can we narrow the range of operation, decrease the possible complications and improve the life quality while without bad effect on the outcomes of these low-risk patients? The feasibility and safety of narrowing the scope of operation in selected patients are worthy of further discussion.

Among cases of stage IA2-IB1 cervical cancer which should have received radical hysterectomy with pelvic lymphadenectomy according to the guideline of NCCN 2014, there were 290 (56.5%) cases whose actual resection width of parametrial tissues of at least one side \<3cm, which is mostly varied mostly due to tumor size, performance of surgeons and the objective conditions of patients. We analyzed these cases and found out that the recurrence rate was 1.4% for low-risk patients, which was lower than 9.5% for other patients. Among all low-risk patients, the recurrence rate of those with the resection width of parametrial tissues of at least one side \<3cm (group B) was 1.8%, which had no statistically difference with that (0.1%) of patients with the resection width of parametrial tissues of both sides ≥3cm (group A). Among all high-risk patients, the recurrence rate of group B was 13.5% and also had no statistically difference with that of group A (6.3%), which may be due to the adjuvant chemotherapy, radiotherapy or both after the operation. The PFS and OS of high-risk patients, even with the help of adjuvant chemotherapy, radiotherapy or both after the operation, were still lower than those of low-risk patients. The resection width of parametrial tissues had no statistically significant effect on the PFS and OS of low-risk patients and further supported the feasibility and safety of narrowing the range of operation in low-risk patients, which was also supported by another paper [@B8].

But how can we accurately value those patients of cervical cancer before operation since the staging of cervical cancer is based on clinical characteristics? How can we exclude the high-risk factors? The magnetic resonance imaging (MRI) and pelvic reconstruction can help with the accurate assessment of the diameter of tumor and the depth of cervical myometrial invasion. So the accurate assessment of lymph vascular involvement becomes a key point of excluding the high-risk factors before operation.

The D2-40 antibody plays an important role in routine histopathologic diagnostics of normal lymphatic vessels and lymphaticderived tumors [@B9]. Platelet/endothelial cell adhesion molecule-1 (CD31) is a cell adhesion and signaling molecule which plays in the biology of blood and vascular cells [@B10]. So we used strong positive of D2-40 to stand by the lymphatic vessel invasion and strong positive of CD31 to stand by the vascular invasion of cervical cancer, and found out that strong positive of D2-40 and CD31 may suggest the parametrial metastases, although the expressive level of CD31 and D2-40 had no relationship with the recurrence and death of cervical cancer. So we can make a fairly precise assessment of whether there is lymph vascular involvement or not by immunohistochemical examination of the expressive level of CD31 and D2-40 in the specimens of cervical biopsy or loop electrosurgical excision procedure of patients with cervical cancer.

There are some limitations to this study. The expression status of D2-40 and CD31 were not represented by the density of the lymphatic ducts and blood vessels. Due to the length of the study and the number of cases included, it was difficult to suggest the exact size of narrowing resection of parametrial tissues which is feasible and safe for low-risk patients.

In summary, this retrospective analysis has shown that the diameter of tumor \>2cm, the depth of cervical myometrial invasion ≥1/2 and lymph vascular involvement are all independent high-risk factors of parametrial metastases, and further highly related to the outcomes of stage IA2-IB1 cervical cancer. Low-risk patients without any of these three high-risk factors have fairly optimistic outcomes, and narrowing the range of operation, which means narrowing resection of parametrial tissues (\<3cm), is feasible and safe for low-risk patients. MRI, combined with the immunohistochemical examination of D2-40 and CD31, can help with excluding the high-risk factors before operation.
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###### 

The whole picture of 880 patients with stage IA2-IB1 cervical cancer.

  ----------------------------------------------------------------------------------------------------------------
  characteristics                                                                              cases (percent,%)
  -------------------------------------------------------------------------------------------- -------------------
  pathological type                                                                            

  squamous cell carcinoma                                                                      718 (81.6)

  adenocarcinoma                                                                               131 (14.9)

  adenosquamous carcinoma                                                                      19 (2.2)

  special type                                                                                 12 (1.4)

  NCCN 2014 staging                                                                            

  ⅠA2                                                                                          26 (3.0)

  ⅠB1                                                                                          854 (97.0)

  Depth of cervical myometrial invasion                                                        

  \<1/2                                                                                        527 (59.9)

  ≥1/2                                                                                         353 (40.1)

  Diameter of tumor                                                                            

  ≤2cm                                                                                         513 (58.3)

  \>2cm                                                                                        367 (41.7)

  Lymph vascular involvement                                                                   

  no                                                                                           591 (67.2)

  yes                                                                                          289 (32.8)

  Parametrial metastases                                                                       

  no                                                                                           859 (97.6)

  yes                                                                                          21 (2.4)

  Resection width of parametrial tissues of 513 cases with well following up                   

  Both sides≥3cm                                                                               223 (43.5)

  At least one side\<3cm                                                                       290 (56.5)

  Immunohistochemical examinations of CD31(542 cases without parametrial metastases)           

  CD31-                                                                                        226 (41.7)

  CD31+                                                                                        180 (33.2)

  CD31++                                                                                       136 (25.1)

  Immunohistochemical examinations of D2-40(585 cases without parametrial metastases) D2-40-   234 (40.0)

  D2-40+                                                                                       181 (30.9)

  D2-40++                                                                                      170 (29.1)

  Outcomes of 513 cases with well following up                                                 

  survival\                                                                                    456 (88.9)\
  recurrence                                                                                   31 (6.0)

  death                                                                                        26 (5.1)
  ----------------------------------------------------------------------------------------------------------------

###### 

The relationship of the diameter of tumor, the depth of cervical myometrial invasion, lymph vascular involvement and parametrial metastases.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables\                              Depth of cervical myometrial invasion (cases)   Lymph vascular involvement\   Parametrial metastases\   P value              
  (n=880)                                                                                 (cases)                       (cases)                                        
  --------------------------------------- ----------------------------------------------- ----------------------------- ------------------------- --------- ----- ---- -------------
  Diameter of tumor                                                                                                                                                    0.000\*

  ≤2cm                                    415                                             98                            406                       107       510   3    0.000\*\*

  \>2cm                                   111                                             256                           185                       182       349   18   0.000\*\*\*

  Depth of cervical myometrial invasion                                                                                                                                

  \<1/2                                                                                                                 438                       89        524   3    0.000\#

  ≥1/2                                                                                                                  153                       200       335   18   0.000\#\#

  Lymph vascular involvement                                                                                                                                           

  \-                                                                                                                                                        587   4    0.000

  \+                                                                                                                                                        272   17   

  CD31                                                                                                                                                                 

  \-                                                                                                                                                        226   3    0.320

  \+                                                                                                                                                        180   6    

  ++                                                                                                                                                        136   12   0.002

  D2-40                                                                                                                                                                

  \-                                                                                                                                                        234   4    0.478

  \+                                                                                                                                                        181   6    

  ++                                                                                                                                                        170   11   0.016
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Note:

\* The relationship of the diameter of tumor and the depth of cervical myometrial invasion

\*\* The relationship of the diameter of tumor and lymph vascular involvement

\*\*\* The relationship of the diameter of tumor and parametrial metastases

\# The relationship of the depth of cervical myometrial invasion and lymph vascular involvement

\#\# The relationship of the depth of cervical myometrial invasion and parametrial metastases.

###### 

The high-risk factors of recurrence and death of cervical cancer.

  -------------------------------------------------------------------------
  Variables\               Recurrence   P    Death   P value        
  (n=513\*)                                                         
  ------------------------ ------------ ---- ------- --------- ---- -------
  Parametrial metastases                                            

  No                       473          28   0.030   478       23   0.019

  Yes                      9            3            9         3    

  CD31                                                              

  \-                       123          13   0.231   126       9    0.712

  \+                       104          6            105       5    

  ++                       28           7    0.156   79        6    0.911

  D240                                                              

  \-                       123          13   0.119   126       9    0.271

  \+                       108          5            109       4    

  ++                       91           9    0.884   92        8    0.520
  -------------------------------------------------------------------------

Note: \* 513 cases with well following up.

###### 

The relationship of the resection width of parametrial tissues and the recurrence and death of cervical cancer

  --------------------------------------------------------------------------
  Parametrial\              Recurrence   P    Death   P value        
  (cases)                                                            
  ------------------------- ------------ ---- ------- --------- ---- -------
  Low-risk group (n=218)                                             

  \<3cm                     112          2    1.000   112       2    1.000

  ≥3cm                      103          1            103       1    

  High-risk group (n=295)                                            

  \<3cm                     155          21   0.082   159       17   0.147

  ≥3cm                      112          7            113       6    
  --------------------------------------------------------------------------

Note: This includes 513 cases with well following up.
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